** Shares of German medical diagnostics provider Synlab
SYAB.DE surge more than 21% to 9.88 euros after UK private
equity firm Cinven says it will launch a public acquisition
offer for the company
** The offer price is 10 euros per Synlab share
** Cinven had in March submitted a non-binding offer to take
over Synlab for the same price
** Synlab has signed an investment agreement with Ephios
Luxembourg and its unit Ephios Bidco, which are controlled by
funds managed or advised by Cinven
** The Synlab shares are on track for best day since March
13, when they gained nearly 35% driven by Cinven's offer
(Reporting by Anastasiia Kozlova)
((Anastasiia.Kozlova@thomsonreuters.com))